Skip to main content

WELLS FARGO & COMPANY/MN

Position in CCCC — C4 Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,114,113
-$168,492 QoQ
Shares Held
452,701
-47.8% QoQ
Ownership
0.368%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 147 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in CCCC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. CCCC ranks #99 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CCCC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,114,113 452,701
2026-03-31 $2,282,605 867,911
2025-12-31 $1,545,686 809,260
2025-09-30 $41,425 18,660
2025-06-30 $2,186 1,529
2025-03-31 $837,790 523,619
2024-12-31 $130,701 36,306
2024-09-30 $153,426 26,917
2024-06-30 $119,015 25,761
2024-03-31 $2,924 358
2023-12-31 $7,355 1,302
2023-09-30 $621 334
2023-06-30 $855 311
2023-03-31 $23,509 7,487
2022-09-30 $54,451 6,209
2022-06-30 $3,785 502
2022-03-31 $455,699 18,784
2021-12-31 $1,005,541 31,228
2021-09-30 $1,267,838 28,376
2021-06-30 $1,323 35
2021-03-31 $195,269 5,279
2020-12-31 $1,276,398 38,527